Package 31722-067-01

{"route": ["ORAL"], "spl_id": "2d0de4b4-d4ee-3593-e063-6294a90ab0cc", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993503", "993518", "993536"], "spl_set_id": ["f69b322b-93ab-407a-bf25-fe13c6896ca6"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE (31722-067-01)", "package_ndc": "31722-067-01", "marketing_start_date": "20230531"}, {"sample": false, "description": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE (31722-067-05)", "package_ndc": "31722-067-05", "marketing_start_date": "20230531"}, {"sample": false, "description": "250 TABLET, EXTENDED RELEASE in 1 BOTTLE (31722-067-25)", "package_ndc": "31722-067-25", "marketing_start_date": "20230531"}, {"sample": false, "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (31722-067-60)", "package_ndc": "31722-067-60", "marketing_start_date": "20230531"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (31722-067-90)", "package_ndc": "31722-067-90", "marketing_start_date": "20230531"}], "brand_name": "Bupropion hydrochloride", "product_id": "31722-067_2d0de4b4-d4ee-3593-e063-6294a90ab0cc", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "31722-067", "generic_name": "Bupropion hydrochloride", "labeler_name": "Camber Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion hydrochloride", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA216800", "marketing_category": "ANDA", "marketing_start_date": "20230531", "listing_expiration_date": "20261231"}